logo
Select company
Select metric
$ -11.46MNet Cash Flow - Change in Cash & Cash Equivalents
VS
Market
30
Sector
33
Industry
36
History
18
$ 2.37Close
$ 1.9 - $ 3.9 52-Week Range
Ticker Information

Ticker

LSTA

Company Name

LISATA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

LISATA THERAPEUTICS INC - Net Cash Flow - Change in Cash & Cash Equivalents Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

LSTA - CF - Chg. Cash Historical data
DateNet Cash Flow - Change in Cash & Cash Equivalents
6/30/2025$ -11.46M
3/31/2025$ -1.59M
12/31/2024$ -6.38M
9/30/2024$ -12.92M
6/30/2024$ 4.6M
3/31/2024$ -6.35M
12/31/2023$ -9.56M
9/30/2023$ 950K
6/30/2023$ -9.66M
3/31/2023$ 15.41M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • LISATA THERAPEUTICS INC's latest trailing twelve months (TTM) CF - Chg. Cash stands at $ 8.48M.
  • Over the past 5 years, LISATA THERAPEUTICS INC's average CF - Chg. Cash has been $ -68.25K.
  • The median CF - Chg. Cash for LISATA THERAPEUTICS INC during this period was $ -319K
  • LISATA THERAPEUTICS INC reached its highest CF - Chg. Cash over the past 5 years at $ 20.41M.
  • The lowest CF - Chg. Cash recorded by LISATA THERAPEUTICS INC in the same timeframe $ -16M

LISATA THERAPEUTICS INC's CF - Chg. Cash vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Chg. Cash Benchmarks
CompanyCF - Chg. Cash
SONN : SONNET BIOTHERAPEUTICS HOLDINGS INC $ -3.23MRLYB : RALLYBIO CORP $ -7.23MICU : SEASTAR MEDICAL HOLDING CORP $ 5.12MCLSD : CLEARSIDE BIOMEDICAL INC $ -8.86MIGC : IGC PHARMA INC $ -1.37MRANI : RANI THERAPEUTICS HOLDINGS INC $ 5.7MLEXX : LEXARIA BIOSCIENCE CORP $ -3.87MAPRE : APREA THERAPEUTICS INC $ -12.17MPLUR : PLURI INC $ -475KLYRA : LYRA THERAPEUTICS INC $ -2.12M

Similar metrics to CF - Chg. Cash:

Definition of Net Cash Flow - Change in Cash & Cash Equivalents

[Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]

LSTA - Net Cash Flow - Change in Cash & Cash Equivalents, Last 5 years

$ -16M

Minimum

Mar 31, 2022

$ 20.41M

Maximum

Jun 30, 2022

$ -68.25K

Average

$ -319K

Median

CF - Chg. Cash Benchmark Analysis

 The chart above depicts the distribution of CF - Chg. Cash for companies in the Total Stock Market. The average CF - Chg. Cash of the companies is $ 1.18M with a standard deviation of $ 45.08M.
The following table provides additional summary stats:
CF - Chg. Cash in the Market:
filtered constituents3.34K
min$ -137M
max$ 138.09M
average$ 1.18M
median$ 116.12K
std$ 45.08M